Back to search

Pamidronate Reduces PTH-mediated bone loss in a gene transfer model of hyperparathyroidism in rats

Data up to Jan 2025

Published1991
Citations16
References13

Total Citations Per Year

Abstract

References (13)

Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivo

1969 • 758 citations

Skeletal disease in primary hyperparathyroidism

1989 • 616 citations

The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats

1991 • 375 citations

Clinical Disorders of Bone and Mineral Metabolism

1983 • 307 citations

Quantitative Digital RadiographyVersusDual Photon Absorptiometry of the Lumbar Spine*

1988 • 216 citations

Effects of Dichloromethylene Diphosphonate on Serum and Urinary Calcium in Primary Hyperparathyroidism

1981 • 93 citations

Experimental Hyperparathyroidism from Multiple Isologous Parathyroid Transplants: Homeostatic Effect of Simultaneous Thyroid Transplants11

1966 • 72 citations

Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate

1982 • 48 citations

Ability of different techniques of measuring bone mass to determine vertebral bone loss in aging female rats

1988 • 37 citations

Bone mineral analysis of the rat femur by direct photon absorptiometry

1981 • 32 citations

Effect of calcitonin on total body bone mineral contents of experimental osteoporotic rats determined by dual photon absorptiometry

1990 • 17 citations

AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE TREATMENT OF HYPERCALCEMIC CRISIS DUE TO PRIMARY HYPERPARATHYROIDISM

1987 • 17 citations

Human parathyroid hormone 1-34-mediated hypercalcemia in a rat model, and its inhibition by dichloromethane diphosphonate

1981 • 11 citations

Cited By (0)

Loading...